Tim Xiao

Oncomyx Therapeutics, Inc. develops and operates software platform to orchestrate an immune response and treat cancer. Its platform's features include non-human pathogen, immuno-stimulatory, ability to multi-arm, and systemic delivery. The company was founded by Steve Potts, Michael Wood, Grant McFadden and is headquartered in Phoenix, AZ.

Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong.

Sichuan Clover Biopharmaceuticals, Inc is a clinical-stage biotechnology company based in Chengdu, China. Clover Biopharmaceuticals' mission is to leverage their trimer-tag technology and in-house manufacturing capabilities to develop and deliver innovative and affordable medical solutions. The Chinese company is committed to partnering with leading healthcare organizations to advance their breakthrough pipeline programs and deliver them to patients. The company's pipeline includes many vaccine and therapeutic candidates for the treatment of infectious disease, cancer, and autoimmune disease, created using trimer-tag platform technology. The company was founded in 2007 by Peng Liang, and Joshua Liang has been the CEO of the company since 2016.

Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany.

Intrinsic Therapeutics, Inc. develops device-based therapies for soft-tissue injuries of the spine. It offers surgeons and patients better options for treating painful disc herniations that cause sciatica and low back pain. The company was founded by Gregory H. Lambrecht in 1999 and is headquartered in Woburn, MA.

STRM.Bio, Inc. is a pre-clinical biotechnology company based in Cambridge, MA. The company's goal is to make gene therapy safe for repeat dosing and to provide a future of medicine for patients with rare diseases worldwide. The company, which was founded by Jonathan Thon and has had him as CEO since incorporation, is backed by venture capital and focuses on developing and delivering targeted gene therapies using extracellular vesicles.

Delos Capital LLC (Delos Capital) is a private equity firm founded in 2013 by Mattew Constantino. The firm is headquartered in New York.

Luqa Pharmaceuticals operates as a pharmaceutical company, acquires, develops, and commercializes healthcare products. It offers products for derma and aesthetics that include Ebernet, an eberconazole cream for the treatment of fungal infections of the skin; and Strataderm, a silicone gel formulation for the treatment of old and new scars, as well as abnormal scar prevention in the form of hypertrophic scars and keloids. The company was founded by Luo Beiwei in 2010 and is headquartered in Shanghai, China.